651749-97-2

Upstream product

• 198022-08-1 (3S,4R)-1-[bis(trimethylsilyl)methyl]-4-isobutyl-3-[(4S)-4-phenyl-2-oxo-oxazolidin-3-yl]-azetidin-2-one 
• 100-52-7 benzaldehyde 

Downstream Products

• 651750-00-4 (3S,4R)-1-(3-aza-4-benzyloxycarbonyl-4-methyl-2-oxopentyl)-3-benzyl-3-tert-butoxycarbonylamino-4-isobutylazetidin-2-one 
• 651749-99-4 (3S,4R)-3-benzyl-1-[bis(trimethylsilyl)methyl]-3-tert-butoxycarbonylamino-4-isobutylazetidin-2-one 
• 651749-74-5 (3S,4R)-3-benzyl-3-tert-butoxycarbonylamino-1-carboxymethyl-4-isobutylazetidin-2-one 
• 651749-98-3 (3R,4R)-3-amino-3-benzyl-4-isobutyl-1-[bis(trimethylsilyl)methyl]azetidin-2-one 
• 651749-71-2 (3S,4R)-3-benzyl-3-tert-butoxycarbonylamino-4-isobutylazetidin-2-one 
• 651749-70-1 (3S,4R)-3-benzyl-3-benzylideneamino-4-isobutyl-1-[bis(trimethylsilyl)methyl]azetidin-2-one 

Relevant academic research and scientific papers

Development of a New Family of Conformationally Restricted Peptides as Potent Nucleators of β-Turns. Design, Synthesis, Structure, and Biological Evaluation of β-Lactam Peptide Analogue of Melanostatin

Novel enantiopure (i)-(β-lactam)-(Gly)-(i+3) peptide models, defined by the presence of a central α-alkyl-αamino-β-lactam ring placed as the (i+1) residue, have been synthesized in a totally stereocontrolled way by α-alkylation of suitable N-[bis(trimethy